Treatment strategies for patients with non-insulin-dependent diabetes mellitus.
Strategies for the treatment of patients with non-insulin-dependent diabetes mellitus are discussed. In order to achieve treatment goals, diet and exercise remain important components of an overall treatment program that may include sulfonylurea drugs, especially in cases where patients are of normal weight or only slightly obese, have had the disease less than five years, and are taking little or no insulin. Failure to control blood sugar levels with sulfonylurea drugs may lead to combining this therapy with insulin or administering insulin alone, regardless of patients' weights.
D001120:Arginine; D001786:Blood Glucose / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D001835:Body Weight; D002747:Chlorpropamide / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000178:diet therapy / Q000188:drug therapy / Q000628:therapy*; D004038:Diet, Reducing; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004043:Dietary Fiber / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D005082:Physical Exertion; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors
D001786:Blood Glucose; D001798:Blood Proteins; D004040:Dietary Carbohydrates; D004043:Dietary Fiber; D007328:Insulin; D013453:Sulfonylurea Compounds; D001120:Arginine; D002747:Chlorpropamide